Altimmune Stock Options

ALT Stock  USD 6.86  0.15  2.24%   
Altimmune's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.23 with a put-to-call open interest ratio of 0.18 over 38 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025. The total put volume is at 20.0, with calls trading at the volume of 3.2 K. This yields a 0.01 put-to-call volume ratio.

Open Interest Against March 21st 2025 Option Contracts

Altimmune option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Altimmune's lending market. For example, when Altimmune's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Altimmune, he or she must hedge the risk by shorting Altimmune stock over its option's life.
The chart above shows Altimmune's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Altimmune's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Altimmune's option, there is no secondary market available for investors to trade.

Altimmune Maximum Pain Price Across 2025-03-21 Option Contracts

Max pain occurs when Altimmune's market makers reach a net positive position across all Altimmune's options at a strike price where option holders stand to lose the most money. By contrast, Altimmune's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Altimmune

Analyzing Altimmune's in-the-money options over time can help investors to take a profitable long position in Altimmune regardless of its overall volatility. This is especially true when Altimmune's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Altimmune's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Altimmune's stock while costing only a fraction of its price.

Altimmune In The Money Call Balance

When Altimmune's strike price is surpassing the current stock price, the option contract against Altimmune stock is said to be in the money. When it comes to buying Altimmune's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Altimmune are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Altimmune Current Options Market Mood

Altimmune's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Altimmune Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Altimmune's options investors are not very successful. Altimmune's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Altimmune contract

Base on the Rule 16, the options market is currently suggesting that Altimmune will have an average daily up or down price movement of about 0.0769% per day over the life of the 2025-03-21 option contract. With Altimmune trading at USD 6.86, that is roughly USD 0.005274. If you think that the market is fully incorporating Altimmune's daily price movement you should consider buying Altimmune options at the current volatility level of 1.23%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Altimmune options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Altimmune calls. Remember, the seller must deliver Altimmune stock to the call owner when a call is exercised.

Altimmune Option Chain

When Altimmune's strike price is surpassing the current stock price, the option contract against Altimmune stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Altimmune's option chain is a display of a range of information that helps investors for ways to trade options on Altimmune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Altimmune. It also shows strike prices and maturity days for a Altimmune against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ALT250321C00002000402.04.5 - 6.24.87In
Call
ALT250321C000030004633.03.8 - 4.03.63In
Call
ALT250321C000040001234.02.65 - 3.13.14In
Call
ALT250321C000050001545.01.4 - 2.52.2In
Call
ALT250321C000060002426.01.45 - 1.61.55In
Call
ALT250321C0000700014947.01.0 - 1.151.05Out
Call
ALT250321C0000800010938.00.6 - 0.80.73Out
Call
ALT250321C0000900015979.00.45 - 0.60.52Out
Call
ALT250321C00010000180810.00.35 - 0.450.44Out
Call
ALT250321C0001100092311.00.25 - 0.350.3Out
Call
ALT250321C00012000196112.00.25 - 0.30.3Out
Call
ALT250321C00013000322413.00.2 - 0.250.2Out
Call
ALT250321C00014000216514.00.15 - 0.20.16Out
Call
ALT250321C00015000227415.00.1 - 0.20.17Out
Call
ALT250321C0001600027516.00.1 - 0.150.15Out
Call
ALT250321C0001700030917.00.0 - 0.150.15Out
Call
ALT250321C0001800059718.00.0 - 0.150.08Out
Call
ALT250321C000190001419.00.0 - 0.150.1Out
Call
ALT250321C00020000134920.00.0 - 0.150.1Out
 Put
ALT250321P0000200082.00.0 - 0.750.3Out
 Put
ALT250321P00003000433.00.0 - 0.750.3Out
 Put
ALT250321P00004000374.00.05 - 0.150.15Out
 Put
ALT250321P000050001995.00.0 - 0.40.3Out
 Put
ALT250321P000060009756.00.55 - 0.70.64Out
 Put
ALT250321P000070004797.01.05 - 1.21.1In
 Put
ALT250321P0000800011388.01.75 - 1.851.8In
 Put
ALT250321P000090004489.02.55 - 2.652.8In
 Put
ALT250321P0001000027710.03.4 - 3.63.95In
 Put
ALT250321P000110005011.04.3 - 4.54.02In
 Put
ALT250321P000120002112.05.2 - 5.44.4In
 Put
ALT250321P000130002613.06.1 - 6.45.5In
 Put
ALT250321P00014000014.06.9 - 8.26.9In
 Put
ALT250321P00015000015.08.1 - 9.06.81In
 Put
ALT250321P00016000016.08.8 - 10.08.8In
 Put
ALT250321P00017000017.09.9 - 11.09.9In
 Put
ALT250321P00018000018.010.5 - 12.510.5In
 Put
ALT250321P00019000019.011.6 - 13.111.6In
 Put
ALT250321P00020000020.013.0 - 14.413.2In

Altimmune Market Cap Over Time

   Market Cap   
       Timeline  

Altimmune Total Stockholder Equity

Total Stockholder Equity

234.37 Million

At this time, Altimmune's Total Stockholder Equity is comparatively stable compared to the past year.

Altimmune Corporate Management

Scot RobertsChief Scientific OfficerProfile
Tony BSVice ManagementProfile
Richard MBAChief OfficerProfile
Kent BSEECo ControllerProfile
Andrew MSCorporate ControllerProfile
Bertrand GeorgesChief OfficerProfile

Additional Tools for Altimmune Stock Analysis

When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.